Socioeconomic deprivation in residential areas does not appear to influence blood-based markers of Alzheimer disease in older men over time.

Individuals with idiopathic intracranial hypertension exhibit distinct circulating lipid and amino acid profiles compared with those who have obesity.

Non-vitamin K oral anticoagulants are associated with modestly slower cognitive decline among patients with atrial fibrillation and Alzheimer disease.

A new algorithm appears to identify hypertension, ischemic heart disease, and cerebrovascular accidents during routine mammography.

Low-carb diets offer greater cardiometabolic benefits beyond managing weight and obesity compared with other popular diets.

Older adults with essential tremor have a higher burden of mild cognitive impairment and dementia than the general population.

Quality of life and functional physical performance are positively associated among people with relapsing-remitting multiple sclerosis.

Following intracerebral hemorrhage, intensive BP lowering reduces risk for recurrent stroke without an increase in serious adverse events.

Traumatic brain injury cause and outcomes vary worldwide, highlighting opportunities to develop tailored preventive care by region.

The FDA approved Zanvastro (zilganersen), the first disease-modifying treatment for Alexander disease in pediatric and adult patients.

The AAN and AHS have issued updated 2026 practice guidelines for the pharmacologic prevention and treatment of migraine among ...

Flexible-dose tavapadon significantly improves motor symptoms among patients with early-stage Parkinson disease.